Experienced medicinal chemist now working with Pharmaron (www.pharmaron.com) to support our clients on the East Coast.Business Development Executive in the discovery, preclinical and CMC spaces at Pharmaron. Extensive, diverse experience in the design and laboratory synthesis of drug-like molecules. Collaborated with multiple CROs/CMOs in Asia and Europe to rapidly achieve desired project goals. Demonstrated record of success in target identification/validation, lead identification, and lead optimization to preclinical candidate selection. Experienced in intellectual property protection and issues related to freedom-to-operate in a pharmaceutical setting, improvement of drug metabolism/pharmacokinetics (DMPK), structural biology and computational chemistry, prodrugs, transition metal catalysis, proprietary synthetic reagent collection design and oversight, small molecule library design and synthesis, and peptide chemistry. Successfully prosecuted targets, including enzyme inhibitors, G-protein coupled receptors, and protein-protein interactions. Additional experience and expertise in immuno-oncology, Gram-positive and Gram-negative bacterial infections, diabetes, obesity, atherosclerosis, hypertension, and neurological disorders.